Table 6.
Molecular Intrinsic Subtypes |
Pharmaceutical Expenditure |
% Expenditure | Patients | % Patients | Median Cost per Patient (25th–75th Percentile) |
---|---|---|---|---|---|
HER2+ | €28,126,333 | 82 | 767 | 33 | €25,105 (€18,115 to €34.058) |
Luminal | €5,161,780 | 15 | 1197 | 52 | €198 (€135 to 3348) |
Triple negative | €1,044,097 | 3 | 344 | 15 | €314 (€154 to 3051) |